Fig leaf tea may help to alleviate atopic dermatitis symptoms in adults: Japanese RCT

By Gary Scattergood

- Last updated on GMT

The researchers concluded that “more trials with a larger number of subjects” were now necessary. GettyImages
The researchers concluded that “more trials with a larger number of subjects” were now necessary. GettyImages

Related tags Skin skin health

Prolonged fig leaf tea consumption may have positive effects on mild atopic dermatitis (AD) in adults, according to a Japanese RCT.

As multiple factors (lifestyle, allergies and skin conditions) contribute to AD, there is currently no known cure and sufferers often must use medication to suppress its symptoms. However, long-term AD medication has side effects, including skin-thinning, stretch marks, increased risk of kidney and liver damage and certain cancers, conjunctivitis and higher blood pressure.

As such, AD sufferers require safer drugs and alternatives. Because researchers at the Toyo Institute of Food Technology in Japan had previously observed positive effects of fig tea on allergy and AD symptoms in animals and cultured cells, they conducted an RCT on patients with mild AD to determine the safety and AD-relieving impact of prolonged consumption of fig leaf tea.

Fig-uring it out

The 30 study participants were aged 20 to 59 and had AD symptoms in the range of 2 to 15 on the Eczema Area and Severity Index (EASI), which was used as the primary outcome. They were randomly assigned to two groups, with one receiving fig leaf tea and the other receiving a placebo of coloured water.

The 12-week study consisted of a four-week non-intervention observation period and an eight-week intervention period, during which each participant consumed either 500ml of fig leaf tea or a placebo daily.

Post-intervention, the researchers reported an improvement in the EASI in the intervention group (+3.2) compared to the placebo group (+2.9), which indicated “a significant decrease in the fig leaf tea group”. 

Additionally, the intervention group had significantly lower EASI values during the fourth week of the study than before it began. But compared to the placebo group, in which seven participants exhibited worsening symptoms by the end of the intervention period, just one participant in the intervention group experienced worsening symptoms and showed no improvement during the RCT.

The researchers were also concerned that fig leaf tea ingestion might be associated with renal function impairment as they observed higher blood chloride levels in the intervention group. However, as there were no significant differences in blood creatinine levels — a key indicator of renal function — in either group, they were satisfied that “prolonged intake of fig leaf tea had no effect on renal function”.

They further noted that while fig leaf tea consumption had positive effects on AD symptoms, the tea had to be mad from fig varieties that did not contain the compound furanocoumarin, which are phototoxic and may cause rashes.

Not so EASI after all

While the researchers acknowledged that the double-blind RCT design of the study was valuable in establishing fig leaf tea’s beneficial effects on AD patients, they also admitted that its small sample size was a limitation.

Another limitation of the study was its sole outcome of EASI value. The researchers wrote that in complex diseases like AD, it was “necessary to evaluate not only EASI values but also TARC (thymus and activation-regulated chemokine) values, TEWL (trans-epidermal water loss)”, subjective symptoms and other signs of disease to determine efficacy.

The researchers concluded that “more trials with a larger number of subjects” ​were necessary to “obtain statistically and clinically meaningful results”​ on the AD-alleviating effects of long-term fig leaf tea consumption.

 

Source: Nutrients

https://doi.org/10.3390/nu14214470

“Efficacy and Safety of Fig (Ficus carica L.) Leaf Tea in Adults with Mild Atopic Dermatitis: A Double-Blind, Randomized, Placebo-Controlled Preliminary Trial”

Authors: Tatsuya Abe, et al.

Related news

Related products

show more

Empowering Women Through the Life Cycle

Empowering Women Through the Life Cycle

Content provided by Glanbia Nutritionals | 07-Nov-2023 | Product Brochure

As discussions around female empowerment widen, and advances in women’s health access and provision accelerate, the implications for business, healthcare,...

Analyzing the unknown threat from Microplastics

Analyzing the unknown threat from Microplastics

Content provided by Agilent Technologies | 06-Nov-2023 | Infographic

Microplastics are any plastic-derived synthetic solid particle or polymeric matrix, ranging in size from 1 µm to 5 mm and insoluble in water.

Pycnogenol® Supports Cognitive Function

Pycnogenol® Supports Cognitive Function

Content provided by Horphag Research | 18-Sep-2023 | White Paper

Clinical research shows daily supplementation with Pycnogenol® may help support brain function in a variety of age groups with results showing improved...

Mastering taste challenges in good-for-you products

Mastering taste challenges in good-for-you products

Content provided by Symrise | 12-Sep-2023 | White Paper

When food and beverage manufacturers reduce sugar, salt, or fat and add fibers, minerals or vitamins, good-for-you products can suffer from undesirable...

Related suppliers

Follow us

Products

View more

Webinars

Food & Beverage Trailblazers

F&B Trailblazers Podcast